The most common adverse events (AEs) in the whole studied group were as follows: increased aspartate aminotransferase (AST) (31%), anemia (22%), increased alanine aminotransferase (ALT) (21%), constipation (21%), hypertension (20%), and neutropenia (19%). This evidence concerns the gene GPT and neutropenia.